[HTML][HTML] Coagulation and anticoagulation in COVID-19
T Hadid, Z Kafri, A Al-Katib - Blood Reviews, 2021 - Elsevier
COVID-19 has become a pandemic in the United States and worldwide. COVID-19-induced
coagulopathy (CIC) is commonly encountered at presentation manifested by considerable
elevation of D-dimer and fibrin split products but with modest or no change in activated
partial thromboplastin time and prothrombin time. CIC is a complex process that is distinctly
different from conventional sepsis-induced coagulopathy. The cytokine storm induced by
COVID-19 infection appears to be more severe in COVID-19, resulting in development of …
coagulopathy (CIC) is commonly encountered at presentation manifested by considerable
elevation of D-dimer and fibrin split products but with modest or no change in activated
partial thromboplastin time and prothrombin time. CIC is a complex process that is distinctly
different from conventional sepsis-induced coagulopathy. The cytokine storm induced by
COVID-19 infection appears to be more severe in COVID-19, resulting in development of …